The 2 Faces of JNK Signaling in Cancer

Genes and Cancer

Volumn 4, Issue 9-10, 2013, Pages 397-400

  Tournier, Cathy ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

c Jun; cancer; JNK; MAPK; MKK; Ras

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CYCLIN D1; INTERLEUKIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN;

ADENOCARCINOMA; AUTOPHAGY; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; LIVER CELL CARCINOMA; NEOPLASM; NONHUMAN; ONCOGENE C MYC; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 84890453082     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601913486349     Document Type: Review

References (52)

1. Schütte J,Minna JD,Birrer MJ.Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene.Proc Natl Acad Sci U S A. 1989;86:2257-61.
2. Binétruy B,Smeal T,Karin M.Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.Nature. 1991;351:122-7.
3. Pulverer BJ,Kyriakis JM,Avruch J,Nikolakaki E,Woodgett JR.Phosphorylation of c-jun mediated by MAP kinases.Nature. 1991;353:670-4.
4. Smeal T,Binetruy B,Mercola DA,Birrer M,Karin M.Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.Nature. 1991;354:494-6.
5. Smeal T,Binetruy B,Mercola D, et al.Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73.Mol Cell Biol. 1992;12:3507-13.
6. Hibi M,Lin A,Smeal T,Minden A,Karin M.Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.Genes Dev. 1993;7:2135-48.
7. Dérijard B,Hibi M,Wu IH, et al.JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.Cell. 1994;76:1025-37.
8. Bos TJ,Monteclaro FS,Mitsunobu F, et al.Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences.Genes Dev. 1990;4:1677-87.
9. Håvarstein LS,Morgan IM,Wong WY,Vogt PK.Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation.Proc Natl Acad Sci U S A. 1992;89:618-22.
10. Kallunki T,Su B,Tsigelny I, et al.JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation.Genes Dev. 1994;8:2996-3007.
11. Alani R,Brown P,Binétruy B, et al.The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells.Mol Cell Biol. 1991;11:6286-95.
12. Davis RJ.Signal transduction by the JNK group of MAP kinases.Cell. 2000;103:239-52.
13. Dérijard B,Raingeaud J,Barrett T, et al.Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.Science. 1995;267:682-5.
14. Tournier C,Whitmarsh AJ,Cavanagh J,Barrett T,Davis RJ.Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase.Proc Natl Acad Sci U S A. 1997;94:7337-42.
15. Wang X,Destrument A,Tournier C.Physiological roles of MKK4 and MKK7: insights from animal models.Biochim Biophys Acta. 2007;1773:1349-57.
16. Kuan CY,Yang DD,Roy DRS,Davis RJ,Rakic P,Flavell RA.The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.Neuron. 1999;22:667-76.
17. Whitmarsh AJ,Davis RJ.Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways.J Mol Med. 1996;74:589-607.
18. Yang DD,Kuan CY,Whitmarsh AJ, et al.Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene.Nature. 1997;389:865-70.
19. Weston CR,Davis RJ.The JNK signal transduction pathway.Curr Opin Cell Biol. 2007;19:142-9.
20. Xu P,Das M,Reilly J,Davis RJ.JNK regulates FoxO-dependent autophagy in neurons.Genes Dev. 2011;25:310-22.
21. Levine B,Klionsky DJ.Development by self-digestion: molecular mechanisms and biological functions of autophagy.Dev Cell. 2004;6:463-77.
22. Tournier C,Hess P,Yang DD, et al.Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.Science. 2000;288:870-4.
23. Wei Y,Pattingre S,Sinha S,Bassik M,Levine B.JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy.Mol Cell. 2008;30:678-88.
24. Bassik MC,Scorrano L,Oakes SA,Pozzan T,Korsmeyer SJ.Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis.EMBO J. 2004;23:1207-16.
25. Wei Y,Sinha S,Levine B.Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation.Autophagy. 2008;4:949-51.
26. Ventura JJ,Hübner A,Zhang C,Flavell RA,Shokat KM,Davis RJ.Chemical genetic analysis of the time course of signal transduction by JNK.Mol Cell. 2006;21:701-10.
27. Das M,Jiang F,Sluss HK, et al.Suppression of p53-dependent senescence by the JNK signal transduction pathway.Proc Natl Acad Sci U S A. 2007;104:15759-64.
28. Wada T,Joza N,Cheng HY, et al.MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence.Nat Cell Biol. 2004;6:215-26.
29. Johnson R,Spiegelman B,Hanahan D,Wisdom R.Cellular transformation and malignancy induced by ras require c-jun.Mol Cell Biol. 1996;16:4504-11.
30. Behrens A,Jochum W,Sibilia M,Wagner EF.Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation.Oncogene. 2000;19:2657-63.
31. Cellurale C,Sabio G,Kennedy NJ, et al.Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.Mol Cell Biol. 2011;31:1565-76.
32. Nielsen C,Thastrup J,Bøttzauw T,Jäättelä M,Kallunki T.c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.Cancer Res. 2007;67:178-85.
33. Kennedy NJ,Sluss HK,Jones SN,Bar-Sagi D,Flavell RA,Davis RJ.Suppression of Ras-stimulated transformation by the JNK signal transduction pathway.Genes Dev. 2003;17:629-37.
34. Whitmarsh AJ,Davis RJ.Role of mitogen- activated protein kinase kinase 4 in cancer.Oncogene. 2007;26:3172-84.
35. Abel EL,Angel JM,Kiguchi K,DiGiovanni J.Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.Nat Protoc. 2009;4:1350-62.
36. She QB,Chen N,Bode AM,Flavell RA,Dong Z.Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.Cancer Res. 2002;62:1343-8.
37. Schramek D,Kotsinas A,Meixner A, et al.The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression.Nat Genet. 2011;43:212-9.
38. Ahn YH,Yang Y,Gibbons DL, et al.Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.Mol Cell Biol. 2011;31:4270-85.
39. Cellurale C,Weston CR,Reilly J, et al.Role of JNK in a Trp53-dependent mouse model of breast cancer.PLoS One. 2010;5:e12469.
40. Cellurale C,Girnius N,Jiang F, et al.Role of JNK in mammary gland development and breast cancer.Cancer Res. 2012;72:472-81.
41. Chen P,O'Neal JF,Ebelt ND, et al.Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model.PLoS One. 2010;5:e10443.
42. Hübner A,Mulholland DJ,Standen CL, et al.JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate.Proc Natl Acad Sci U S A. 2012;109:12046-51.
43. Chen N,Nomura M,She QB, et al.Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.Cancer Res. 2001;61:3908-12.
44. Finegan KG,Tournier C.The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.Cancer Res. 2010;70:5797-806.
45. Shibata W,Maeda S,Hikiba Y, et al.c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice.Cancer Res. 2008;68:5031-9.
46. Sakurai T,Maeda S,Chang L,Karin M.Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.Proc Natl Acad Sci U S A. 2006;103:10544-51.
47. Hui L,Zatloukal K,Scheuch H,Stepniak E,Wagner EF.Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.J Clin Invest. 2008;118:3943-53.
48. Das M,Garlick DS,Greiner DL,Davis RJ.The role of JNK in the development of hepatocellular carcinoma.Genes Dev. 2011;25:634-45.
49. Chen N,She QB,Bode AM,Dong Z.Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibroblast cells.Cancer Res. 2002;62:1300-4.
50. Greenman C,Stephens P,Smith R, et al.Patterns of somatic mutation in human cancer genomes.Nature. 2007;446:153-8.
51. Kan Z,Jaiswal BS,Stinson J, et al.Diverse somatic mutation patterns and pathway alterations in human cancers.Nature. 2010;466:869-73.
52. Zhang T,Inesta-Vaquera F,Niepel M, et al.Discovery of potent and selective covalent inhibitors of JNK.Chem Biol. 2012;19:140-54.